Skip to content

Programmed intermittent paravertebral block for analgesia and immunosuppression after Video-assisted Thoracoscopic Surgery

Programmed intermittent paravertebral block for analgesia and immunosuppression after Video-assisted Thoracoscopic Surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000028820
Enrollment
Unknown
Registered
2020-01-05
Start date
2020-01-01
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

Group 1:Programmed intermittent paravertebral bolus infusion analgesia
Group 2:Continuous paravertebral block analgesia
Group 0:Intravenous analgesia

Sponsors

Beijing Chest Hospital,Capital Medical Univercity
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Aged 35 to 75 years, no gender restriction, ASA I to III; 2) Non-small cell lung cancer patients; 3) Patients with VATS lobectomy; 4) Patients with clear awareness and good communication.

Exclusion criteria

Exclusion criteria: 1)Patients with abnormal blood coagulation function, infection at puncture site, or perioperative blood transfusion patients 2) Patients with severe cardiovascular and cerebrovascular diseases; 3) Spinal surgery patients; 4) Patients with persistent chronic pain before surgery; 5) Patients who switch to thoracotomy during surgery or who have serious surgical complications requiring secondary surgery; 6) The catheter out; 7) Patients who request to withdraw from the study; 8) Patients with immune system disorder.

Design outcomes

Primary

MeasureTime frame
Pain Visual Analogue Score;

Secondary

MeasureTime frame
Total lymphocytes;Total T lymphocytes;Helper T cells;Regulatory T cells;Cytotoxic T cell;Natural Killer cell;Total B lymphocyte;Interleukin-2;Interleukin-6;Interleukin-6;Interieukin-10;Tumor Necrosis Factor a;transforming growth factor-ß;QoR-15;Catecholamines;Cortisol;

Countries

China

Contacts

Public ContactLiu Wei

Beijing Chest Hospital, Capital Medical Univercity

lw1200@sina.com+86 13621153330

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026